Status:
COMPLETED
A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
Lead Sponsor:
Novartis
Conditions:
Essential Hypertension
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to provide data on the dose response of simvastatin in lowering LDL-C when it is co-administered with valsartan in patients with both essential hypertension and hyperchole...
Eligibility Criteria
Inclusion
- Elevated LDL-Cholesterol
- Essential hypertension
Exclusion
- Severe Hypertension
- Prior or known muscular or neuromuscular disease of any type
- A history of cardiovascular disease
- Hypertension or hypercholesterolemia due to secondary causes
- Uncontrolled diabetes or insulin treatment
- Evidence of hepatic or renal disease
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
871 Patients enrolled
Trial Details
Trial ID
NCT00254475
Start Date
November 1 2005
End Date
September 1 2006
Last Update
August 19 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigative Centers, Germany
2
Novartis Pharmaceuticals
Basel, Switzerland